Cardiol Therapeutics (CRDL) Inventory Average (2020 - 2021)

Cardiol Therapeutics (CRDL) reported Inventory Average of $14445.7 for Q3 2021, down 79.94% quarter-over-quarter from $72027.6 in Q4 2020.

Cardiol Therapeutics (CRDL) Inventory Average (2020 - 2021) Analysis & Trends

Cardiol Therapeutics has reported Inventory Average for 2 years, with the latest figure at $14445.7 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 3.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 2.51 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 180.70 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 131.60 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 66.75 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 1.73 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 266.66 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 63.01 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 79.60 Mn
10 Cardiol Therapeutics 169.92 Mn 149.74 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 14,445.70
Dec 31, 2020 72,027.62